Synergy CHC (SNYR) Cash & Equivalents Growth (3y) (2016 - 2020)
Synergy CHC (SNYR) Cash & Equivalents Growth (3y) (2016 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Mckesson |
105.15 Bn |
101.18 Bn |
4.04 Bn |
-5.28% |
| 2 |
Cencora |
60.58 Bn |
58.40 Bn |
3.59 Bn |
12.24% |
| 3 |
Cardinal Health |
53.81 Bn |
49.87 Bn |
2.50 Bn |
-0.44% |
| 4 |
Henry Schein |
9.71 Bn |
9.57 Bn |
1.07 Bn |
3.08% |
| 5 |
Akso Health |
3.28 Bn |
3.28 Bn |
- |
254.96% |
| 6 |
111 |
651.73 Mn |
572.63 Mn |
23.58 Mn |
-8.72% |
| 7 |
Accendra Health |
248.02 Mn |
-88.86 Mn |
278.03 Mn |
71.45% |
| 8 |
Edap Tms |
230.14 Mn |
215.14 Mn |
8.15 Mn |
-38.15% |
| 9 |
VitaNova Life Sciences |
11.51 Mn |
11.01 Mn |
316,343.00 |
255.14% |
| 10 |
Synergy CHC |
1.63 Mn |
-1.09 Mn |
2.22 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
-61.22% |
| Dec 31, 2019 |
-21.36% |
| Sep 30, 2019 |
-71.28% |
| Jun 30, 2019 |
-64.29% |
| Mar 31, 2019 |
-43.22% |
| Dec 31, 2018 |
-66.56% |
| Sep 30, 2018 |
-45.02% |
| Jun 30, 2018 |
-39.94% |
| Mar 31, 2018 |
-56.69% |
| Dec 31, 2017 |
643.77% |
| Sep 30, 2017 |
668.08% |
| Jun 30, 2017 |
-9.49% |
| Mar 31, 2017 |
763.89% |
| Dec 31, 2016 |
820.30% |
| Mar 31, 2016 |
916.10% |
